Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 11—November 2017

Virulence of Japanese Encephalitis Virus Genotypes I and III, Taiwan

Yi-Chin Fan1, Jen-Wei Lin1, Shu-Ying Liao, Jo-Mei Chen, Yi-Ying Chen, Hsien-Chung Chiu, Chen-Chang Shih, Chi-Ming Chen, Ruey-Yi Chang, Chwan-Chuen King, Wei-June Chen, Yi-Ting Ko, Chao-Chin Chang, and Shyan-Song ChiouComments to Author 
Author affiliations: National Chung Hsing University, Taichung, Taiwan (Y.-C. Fan, J.-W. Lin, S.-Y. Liao, J.-M. Chen, Y.-Y. Chen, C.-M. Chen, Y.-T. Ko, C.-C. Chang, S.-S. Chiou); National Defense Medical Center, Taipei, Taiwan (H.-C. Chiu); Tri-Service General Hospital (H.-C. Chiu); Taiwan Mennonite Christian Hospital, Hualien, Taiwan (C.-C. Shih); Tungs’ Taichung MetroHarbor Hospital, Taichung (C.-M. Chen); National Dong Hwa University, Hualien (R.-Y. Chang); National Taiwan University, Taipei (C.-C. King); Chang Gung University, Taoyuan, Taiwan (W.-J. Chen)

Main Article

Table 1

Descriptive characteristics of populations for study of virulence of JEV genotypes I and III, Taiwan*

Characteristic Region
p value†
Changhua Taipei Pingtung Miaoli Taichung Hualien Taichung Hualien
Year 1994 1995 1999 2000 2010 2010 2012 2012 ND
No. participants 795 886 571 274 510 754 527 300 ND
No. (%) vaccinated 36 41 41 33 48 48 49 46 <0.05
Average age, y‡ 42.8 40.9 47.1 51.3 49.6 48.1 52.0 49.2 <0.05
Male sex, % 45 52 47 54 50 48 52 49 >0.05

*JEV, Japanese encephalitis virus; ND, no data.
†Analyzed by using 1-way analysis of variance.
‡Range 40.9–52.0 y.

Main Article

1These authors contributed equally to this article.

Page created: October 17, 2017
Page updated: October 17, 2017
Page reviewed: October 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.